Anti-PD-1/PD-L1 therapy for renal cell carcinoma: challenges in the development of predictive biomarkers

被引：3
|
作者：
Kato, Renpei [1 ]
Obara, Wataru [1 ]
机构：
[1] Iwate Med Univ, Dept Urol, Morioka, Iwate, Japan
来源：
EXPERT REVIEW OF ANTICANCER THERAPY | 2022年 / 22卷 / 07期
关键词：
anti-PD-1/PD-L1; therapy; biomarker; renal cell carcinoma; PD-L1; expression; peripheral blood biomarkers; CIRCULATING TUMOR DNA; CHECKPOINT; EXPRESSION;
D O I：
10.1080/14737140.2022.2087631
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：667 / 669
页数：3
相关论文
共 50 条
  • [1] Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC
    Niu, Mengke
    Yi, Ming
    Li, Ning
    Luo, Suxia
    Wu, Kongming
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2021, 10 (01)
  • [2] Progress and challenges of predictive biomarkers of anti PD-1/PD-L1 immunotherapy: A systematic review
    Teng, Feifei
    Meng, Xiangjiao
    Kong, Li
    Yu, Jinming
    CANCER LETTERS, 2018, 414 : 166 - 173
  • [3] Predictive Markers for the Efficacy of Anti-PD-1/PD-L1 Antibodies in Lung Cancer
    Shukuya, Takehito
    Carbone, David P.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (07) : 976 - 988
  • [4] Targeting the PD-1/PD-L1 Pathway in Renal Cell Carcinoma
    Kammerer-Jacquet, Solene-Florence
    Deleuze, Antoine
    Saout, Judikael
    Mathieu, Romain
    Laguerre, Brigitte
    Verhoest, Gregory
    Dugay, Frederic
    Belaud-Rotureau, Marc-Antoine
    Bensalah, Karim
    Rioux-Leclercq, Nathalie
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (07)
  • [5] Research Progress of Anti-PD-1/PD-L1 Immunotherapy Related Mechanisms and Predictive Biomarkers in NSCLC
    Bie, Fenglong
    Tian, He
    Sun, Nan
    Zang, Ruochuan
    Zhang, Moyan
    Song, Peng
    Liu, Lei
    Peng, Yue
    Bai, Guangyu
    Zhou, Bolun
    Gao, Shugeng
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [6] Current status and development of anti-PD-1/PD-L1 immunotherapy for lung cancer
    Wang, Luyao
    Ma, Qingxia
    Yao, Ruixue
    Liu, Jia
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 79
  • [7] Predictive and Prognostic Role of PD-L1 in Urothelial Carcinoma Patients with Anti-PD-1/PD-L1 Therapy: A Systematic Review and Meta-Analysis
    Liu, Haoran
    Ye, Tao
    Yang, Xiaoqi
    Lv, Peng
    Wu, Xiaoliang
    Thou, Hui
    Lu, Hongyan
    Tang, Kun
    Ye, Zhangqun
    DISEASE MARKERS, 2020, 2020
  • [8] Hodgkin lymphoma and imaging in the era of anti-PD-1/PD-L1 therapy
    Kirienko, Margarita
    Sollini, Martina
    Chiti, Arturo
    CLINICAL AND TRANSLATIONAL IMAGING, 2018, 6 (06) : 417 - 427
  • [9] Anti-PD-1 and PD-L1 therapy for bladder cancer: what is on the horizon?
    Sundararajan, Srinath
    Vogelzang, Nicholas J.
    FUTURE ONCOLOGY, 2015, 11 (16) : 2299 - 2306
  • [10] Microbiota and Extracellular Vesicles in Anti-PD-1/PD-L1 Therapy
    Mishra, Surbhi
    Amatya, Sajeen Bahadur
    Salmi, Sonja
    Koivukangas, Vesa
    Karihtala, Peeter
    Reunanen, Justus
    CANCERS, 2022, 14 (20)
12345